Sensitive and critical periods during neurotypical and aberrant neurodevelopment: A framework for neurodevelopmental disorders

Neuroscience and Biobehavioral Reviews

Volumn 50, Issue , 2015, Pages 180-188

  Meredith, R M ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Autism; Critical period; Fragile X syndrome; Neurodevelopmental disorder (NDD); Neurotypical; Sensitive period; Synapse; Time window

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BUMETANIDE; FRAGILE X MENTAL RETARDATION PROTEIN; PROTEIN INHIBITOR; SAG1.1; UNCLASSIFIED DRUG; VALPROIC ACID;

AUTISM; BRAIN CORTEX; BRAIN DISEASE; BRAIN STEM; CHROMOSOME 15Q; DCX GENE; DEVELOPMENTAL DISORDER; DOWN SYNDROME; DRUG ACTIVITY; FMR1 GENE; FRAGILE X SYNDROME; GABAERGIC TRANSMISSION; GENE; GENE DISRUPTION; GENE EXPRESSION; INTELLECTUAL IMPAIRMENT; NDD GENE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVE EXCITABILITY; NEURODEVELOPMENTAL DISORDER; NONHUMAN; PATHOGENESIS; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SHORT CIRCUIT CURRENT; SINGLE DRUG DOSE; SOMATOSENSORY CORTEX; SYNAPSE; SYNAPTIC INHIBITION; SYNGAP1 GENE; THALAMUS; VISUAL CORTEX; ANIMAL; BRAIN; CONGENITAL MALFORMATION; GENETICS; HUMAN; LEARNING; METABOLISM; MOUSE; NERVE CELL; NEURODEVELOPMENTAL DISORDERS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; CRITICAL PERIOD (PSYCHOLOGY); GENE EXPRESSION; HUMANS; MICE; NEURODEVELOPMENTAL DISORDERS; NEURONAL PLASTICITY; NEURONS; SYNAPSES;

EID: 84924049354     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.12.001     Document Type: Review

References (128)

1. Abekawa T., Ito K., Nakagawa S., Koyama T. Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats. Psychopharmacology (Berlin) 2007, 192:303-316.
2. Adusei D.C., Pacey L.K., Chen D., Hampson D.R. Early developmental alterations in GABAergic protein expression in fragile X knockout mice. Neuropharmacology 2010, 59:167-171.
3. Amiet C., Gourfinkel-An I., Bouzamondo A., Tordjman S., Baulac M., Lechat P., Mottron L., Cohen D. Epilepsy in autism is associated with intellectual disability and gender: evidence from a meta-analysis. Biol. Psychiatry 2008, 64:577-582.
4. Ascano M., Mukherjee N., Bandaru P., Miller J.B., Nusbaum J.D., Corcoran D.L., Langlois C., Munschauer M., Dewell S., Hafner M., Williams Z., Ohler U., Tuschl T. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature 2012, 492:382-386.
5. Bagni C., Greenough W.T. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat. Rev. Neurosci. 2005, 6:376-387.
6. Bagni C., Tassone F., Neri G., Hagerman R. Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. J. Clin. Invest. 2012, 122:4314-4322.
7. Bai J., Ramos R.L., Ackman J.B., Thomas A.M., Lee R.V., LoTurco J.J. RNAi reveals doublecortin is required for radial migration in rat neocortex. Nat. Neurosci. 2003, 6:1277-1283.
8. Bakker, et al. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium. Cell 1994, 78:23-33.
9. Bayer S.A., Altman J., Russo R.J., Zhang X. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 1993, 14:83-144.
10. Bear M.F., Huber K.M., Warren S.T. The mGluR theory of fragile X mental retardation. Trends Neurosci. 2004, 27:370-377.
11. Belmonte M.K., Allen G., Beckel-Mitchener A., Boulanger L.M., Carper R.A., Webb S.J. Autism and abnormal development of brain connectivity. J. Neurosci. 2004, 24:9228-9231.
12. Ben-Ari Y., Spitzer N.C. Phenotypic checkpoints regulate neuronal development. Trends Neurosci. 2010, 33:485-492.
13. Bender K.J., Rangel J., Feldman D.E. Development of columnar topography in the excitatory layer 4 to layer 2/3 projection in rat barrel cortex. J. Neurosci. 2003, 23:8759-8770.
14. Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res. 2011, 1380:42-77.
15. Bill B.R., Geschwind D.H. Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr. Opin. Genet. Dev. 2009, 19:271-278.
16. Blankenship A.G., Feller M.B. Mechanisms underlying spontaneous patterned activity in developing neural circuits. Nat. Rev. Neurosci. 2010, 11:18-29.
17. Brose N., O'Connor V., Skehel P. Synaptopathy: dysfunction of synaptic function?. Biochem. Soc. Trans. 2010, 38:443-444.
18. Bureau I., Shepherd G.M., Svoboda K. Circuit and plasticity defects in the developing somatosensory cortex of FMR1 knock-out mice. J. Neurosci. 2008, 28:5178-5188.
19. Chamberlain S.J., Lalande M. Neurodevelopmental disorders involving genomic imprinting at human chromosome 15q11-q13. Neurobiol. Dis. 2010, 39:13-20.
20. Chattopadhyaya B., Cristo G.D. GABAergic circuit dysfunctions in neurodevelopmental disorders. Front. Psychiatry 2012, 3:51.
21. Chilton J.K. Molecular mechanisms of axon guidance. Dev. Biol. 2006, 292:13-24.
22. Christensen J., Gronborg T.K., Sorensen M.J., Schendel D., Parner E.T., Pedersen L.H., Vestergaard M. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013, 309:1696-1703.
23. Chuang S.C., Zhao W., Bauchwitz R., Yan Q., Bianchi R., Wong R.K. Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model. J. Neurosci. 2005, 25:8048-8055.
24. Clancy B., Finlay B.L., Darlington R.B., Anand K.J. Extrapolating brain development from experimental species to humans. Neurotoxicology 2007, 28:931-937.
25. Clayton-Smith J., Laan L. Angelman syndrome: a review of the clinical and genetic aspects. J. Med. Genet. 2003, 40:87-95.
26. Clement J.P., Aceti M., Creson T.K., Ozkan E.D., Shi Y., Reish N.J., Almonte A.G., Miller B.H., Wiltgen B.J., Miller C.A., Xu X., Rumbaugh G. Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses. Cell 2012, 151:709-723.
27. Clement J.P., Ozkan E.D., Aceti M., Miller C.A., Rumbaugh G. SYNGAP1 links the maturation rate of excitatory synapses to the duration of critical-period synaptic plasticity. J. Neurosci. 2013, 33:10447-10452.
28. Courchesne E., Redcay E., Morgan J.T., Kennedy D.P. Autism at the beginning: microstructural and growth abnormalities underlying the cognitive and behavioral phenotype of autism. Dev. Psychopathol. 2005, 17:577-597.
29. Crair M.C., Malenka R.C. A critical period for long-term potentiation at thalamocortical synapses. Nature 1995, 375:325-328.
30. Cruz-Martin A., Crespo M., Portera-Cailliau C. Delayed stabilization of dendritic spines in fragile X mice. J. Neurosci. 2010, 30:7793-7803.
31. D'Hulst C., De Geest N., Reeve S.P., Van Dam D., De Deyn P.P., Hassan B.A., Kooy R.F. Decreased expression of the GABA(A) receptor in fragile X syndrome. Brain Res. 2006, 1121:238-245.
32. Darnell J.C., Van Driesche S.J., Zhang C., Hung K.Y., Mele A., Fraser C.E., Stone E.F., Chen C., Fak J.J., Chi S.W., Licatalosi D.D., Richter J.D., Darnell R.B. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 2011, 146:247-261.
33. Das I., Park J.-M., Shin J.H., Jeon S.K., Lorenzi H., Linden D.J., Worley P.F., Reeves R.H. Hedgehog agonist therapy corrects structural and cognitive deficits in a down syndrome mouse model. Sci. Transl. Med. 2013, 5:201ra120.
34. Daw M.I., Ashby M.C., Isaac J.T. Coordinated developmental recruitment of latent fast spiking interneurons in layer IV barrel cortex. Nat. Neurosci. 2007, 10:453-461.
35. Dawson J.E., Raymond A.M., Winn L.M. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice. Toxicol. Appl. Pharmacol. 2006, 211:124-132.
36. Ehninger D., Li W., Fox K., Stryker M.P., Silva A.J. Reversing neurodevelopmental disorders in adults. Neuron 2008, 60:950-960.
37. Eichler E.E., Kunst C.B., Lugenbeel K.A., Ryder O.A., Davison D., Warren S.T., Nelson D.L. Evolution of the cryptic FMR1 CGG repeat. Nat. Genet. 1995, 11:301-308.
38. Fagiolini M., Hensch T.K. Inhibitory threshold for critical-period activation in primary visual cortex. Nature 2000, 404:183-186.
39. Feldmeyer D., Brecht M., Helmchen F., Petersen C.C., Poulet J.F., Staiger J.F., Luhmann H.J., Schwarz C. Barrel cortex function. Prog. Neurobiol. 2013, 103:3-27.
40. Fernandez F., Morishita W., Zuniga E., Nguyen J., Blank M., Malenka R.C., Garner C.C. Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat. Neurosci. 2007, 10:411-413.
41. Fox K. Anatomical pathways and molecular mechanisms for plasticity in the barrel cortex. Neuroscience 2002, 111:799-814.
42. Fox K., Glazewski S., Schulze S. Plasticity and stability of somatosensory maps in thalamus and cortex. Curr. Opin. Neurobiol. 2000, 10:494-497.
43. Galvez R., Greenough W.T. Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome. Am. J. Med. Genet. A 2005, 135:155-160.
44. Gatto C.L., Broadie K. Temporal requirements of the fragile X mental retardation protein in modulating circadian clock circuit synaptic architecture. Front. Neural Circuits 2009, 3:8.
45. Geschwind D.H., Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr. Opin. Neurobiol. 2007, 17:103-111.
46. Gillberg C., Billstedt E. Autism and Asperger syndrome: coexistence with other clinical disorders. Acta Psychiatr. Scand. 2000, 102:321-330.
47. Goldstein S., Reynolds C.R. Handbook of Neurodevelopmental and Genetic Disorders in Children 1999.
48. Goncalves J.T., Anstey J.E., Golshani P., Portera-Cailliau C. Circuit level defects in the developing neocortex of Fragile X mice. Nat. Neurosci. 2013, 16:903-909.
49. Grabrucker A.M., Schmeisser M.J., Schoen M., Boeckers T.M. Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies. Trends Cell Biol. 2011, 21:594-603.
50. Gutierrez-Castellanos N., Winkelman B.H., Tolosa-Rodriguez L., Devenney B., Reeves R.H., De Zeeuw C.I. Size does not always matter: Ts65Dn Down syndrome mice show cerebellum-dependent motor learning deficits that cannot be rescued by postnatal SAG treatment. J. Neurosci. 2013, 33:15408-15413.
51. Han K., Holder J.L., Schaaf C.P., Lu H., Chen H., Kang H., Tang J., Wu Z., Hao S., Cheung S.W., Yu P., Sun H., Breman A.M., Patel A., Lu H.C., Zoghbi H.Y. SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties. Nature 2013, 503:72-77.
52. Harlow E.G., Till S.M., Russell T.A., Wijetunge L.S., Kind P., Contractor A. Critical period plasticity is disrupted in the barrel cortex of FMR1 knockout mice. Neuron 2010, 65:385-398.
53. He Q., Nomura T., Xu J., Contractor A. The developmental switch in GABA polarity is delayed in fragile X mice. J. Neurosci. 2014, 34:446-450.
54. Hensch T.K. Critical period regulation. Annu. Rev. Neurosci. 2004, 27:549-579.
55. Hensch T.K. Critical period plasticity in local cortical circuits. Nat. Rev. Neurosci. 2005, 6:877-888.
56. Hensch T.K., Fagiolini M., Mataga N., Stryker M.P., Baekkeskov S., Kash S.F. Local GABA circuit control of experience-dependent plasticity in developing visual cortex. Science 1998, 282:1504-1508.
57. Hoerder-Suabedissen A., Oeschger F.M., Krishnan M.L., Belgard T.G., Wang W.Z., Lee S., Webber C., Petretto E., Edwards A.D., Molnár Z. Expression profiling of mouse subplate reveals a dynamic gene network and disease association with autism and schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:3555-3560.
58. Horn G. Pathways of the past: the imprint of memory. Nat. Rev. Neurosci. 2004, 5:108-120.
59. Houbaert X., Zhang C.L., Gambino F., Lepleux M., Deshors M., Normand E., Levet F., Ramos M., Billuart P., Chelly J., Herzog E., Humeau Y. Target-specific vulnerability of excitatory synapses leads to deficits in associative memory in a model of intellectual disorder. J. Neurosci. 2013, 33:13805-13819.
60. Johnson M.H. Sensitive periods in functional brain development: problems and prospects. Dev. Psychobiol. 2005, 46:287-292.
61. Johnson M.H. Executive function and developmental disorders: the flip side of the coin. Trends Cogn. Sci. 2012, 16:454-457.
62. Jones K.S., Corbin J.G., Huntsman M.M. Neonatal NMDA receptor blockade disrupts spike timing and glutamatergic synapses in fast spiking interneurons in a NMDA receptor hypofunction model of schizophrenia. PLOS ONE 2014, 9:e109303.
63. Just M.A., Cherkassky V.L., Keller T.A., Minshew N.J. Cortical activation and synchronization during sentence comprehension in high-functioning autism: evidence of underconnectivity. Brain 2004, 127:1811-1821.
64. Kaiser M.D., Hudac C.M., Shultz S., Lee S.M., Cheung C., Berken A.M., Deen B., Pitskel N.B., Sugrue D.R., Voos A.C., Saulnier C.A., Ventola P., Wolf J.M., Klin A., Vander Wyk B.C., Pelphrey K.A. Neural signatures of autism. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:21223-21228.
65. Kang H.J., Kawasawa Y.I., Cheng F., Zhu Y., Xu X., Li M., Sousa A.M., Pletikos M., Meyer K.A., Sedmak G., Guennel T., Shin Y., Johnson M.B., Krsnik Z., Mayer S., Fertuzinhos S., Umlauf S., Lisgo S.N., Vortmeyer A., Weinberger D.R., Mane S., Hyde T.M., Huttner A., Reimers M., Kleinman J.E., Sestan N. Spatio-temporal transcriptome of the human brain. Nature 2011, 478:483-489.
66. Kau A.S., Reider E.E., Payne L., Meyer W.A., Freund L. Early behavior signs of psychiatric phenotypes in fragile X syndrome. Am. J. Ment. Retard. 2000, 105:286-299.
67. Kaufmann W.E., Moser H.W. Dendritic anomalies in disorders associated with mental retardation. Cereb. Cortex 2000, 10:981-991.
68. Klemmer P., Meredith R.M., Holmgren C.D., Klychnikov O.I., Stahl-Zeng J., Loos M., van der Schors R.C., Wortel J., de Wit H., Spijker S., Rotaru D.C., Mansvelder H.D., Smit A.B., Li K.W. Proteomics, ultrastructure, and physiology of hippocampal synapses in a fragile X syndrome mouse model reveal presynaptic phenotype. J. Biol. Chem. 2011, 286:25495-25504.
69. Knudsen E.I. Sensitive periods in the development of the brain and behavior. J. Cogn. Neurosci. 2004, 16:1412-1425.
70. Kroon T., Sierksma M.C., Meredith R.M. Investigating mechanisms underlying neurodevelopmental phenotypes of autistic and intellectual disability disorders: a perspective. Front. Syst. Neurosci. 2013, 7:75.
71. LaFata G., Dominguez-Iturza G.A., Dresselaerts N., Dawitz T., Poorthuis J., Averna R.B., Himmelreich M., Meredith U., Achsel R.M., Dotti T., Bagni C.G.C. FMRP regulates multipolar to bipolar transition affecting neuronal migration and cortical circuitry. Nat. Neurosci. 2014, 17(12):1693-1700. http://www.ncbi.nlm.nih.gov/pubmed/25402856. 10.1038/nn.3870.
72. LeBlanc J.J., Fagiolini M. Autism: a "critical period" disorder?. Neural Plast. 2011, 2011:921680.
73. Lee H.M., Giguere P.M., Roth B.L. DREADDs: novel tools for drug discovery and development. Drug Discov. Today 2014, 19:469-473.
74. Lindhout D., Omtzigt J.G. Pregnancy and the risk of teratogenicity. Epilepsia 1992, 33(Suppl. 4):S41-S48.
75. Lorenz K. Der Kumpan in der Umwelt des Vogels: der Artgenosse als auslösendes Moment sozialer Verhaltungsweisen. J. Ornithol. 1935, 83:37-215. 289-413.
76. Manent J.B., Wang Y., Chang Y., Paramasivam M., LoTurco J.J. Dcx reexpression reduces subcortical band heterotopia and seizure threshold in an animal model of neuronal migration disorder. Nat. Med. 2009, 15:84-90.
77. Maravall M., Stern E.A., Svoboda K. Development of intrinsic properties and excitability of layer 2/3 pyramidal neurons during a critical period for sensory maps in rat barrel cortex. J. Neurophysiol. 2004, 92:144-156.
78. Marin O., Valiente M., Ge X., Tsai L.H. Guiding neuronal cell migrations. Cold Spring Harb. Perspect. Biol. 2010, 2:a001834.
79. Markram K., Markram H. The intense world theory - a unifying theory of the neurobiology of autism. Front. Hum. Neurosci. 2010, 4:224.
80. Martin B.S., Huntsman M.M. Pathological plasticity in fragile X syndrome. Neural Plast. 2012, 2012:275630.
81. Maurer D., Mondloch C.J., Lewis T.L. Sleeper effects. Dev. Sci. 2007, 10:40-47.
82. Maynard K.R., Stein E. DSCAM contributes to dendrite arborization and spine formation in the developing cerebral cortex. J. Neurosci. 2012, 32:16637-16650.
83. Medrihan L., Tantalaki E., Aramuni G., Sargsyan V., Dudanova I., Missler M., Zhang W. Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. J. Neurophysiol. 2008, 99:112-121.
84. Meikle L., Talos D.M., Onda H., Pollizzi K., Rotenberg A., Sahin M., Jensen F.E., Kwiatkowski D.J. A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J. Neurosci. 2007, 27:5546-5558.
85. Meredith R.M., Dawitz J., Kramvis I. Sensitive time-windows for susceptibility in neurodevelopmental disorders. Trends Neurosci. 2012, 35:335-344.
86. Meredith R.M., Mansvelder H.D. STDP and mental retardation: dysregulation of dendritic excitability in Fragile X syndrome. Front. Synap. Neurosci. 2010, 2:10.
87. Michalon A., Sidorov M., Ballard T.M., Ozmen L., Spooren W., Wettstein J.G., Jaeschke G., Bear M.F., Lindemann L. Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron 2012, 74:49-56.
88. Michel G.F., Tyler A.N. Critical period: a history of the transition from questions of when, to what, to how. Dev. Psychobiol. 2005, 46:156-162.
89. Mierau S.B., Meredith R.M., Upton A.L., Paulsen O. Dissociation of experience-dependent and -independent changes in excitatory synaptic transmission during development of barrel cortex. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:15518-15523.
90. Mitchell K.J. The genetics of neurodevelopmental disease. Curr. Opin. Neurobiol. 2011, 21:197-203.
91. Musumeci S.A., Bosco P., Calabrese G., Bakker C., De Sarro G.B., Elia M., Ferri R., Oostra B.A. Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia 2000, 41:19-23.
92. Musumeci S.A., Hagerman R.J., Ferri R., Bosco P., Dalla Bernardina B., Tassinari C.A., De Sarro G.B., Elia M. Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia 1999, 40:1092-1099.
93. Neale B.M., Kou Y., Liu L., Ma'ayan A., Samocha K.E., Sabo A., Lin C.F., Stevens C., Wang L.S., Makarov V., Polak P., Yoon S., Maguire J., Crawford E.L., Campbell N.G., Geller E.T., Valladares O., Schafer C., Liu H., Zhao T., Cai G., Lihm J., Dannenfelser R., Jabado O., Peralta Z., Nagaswamy U., Muzny D., Reid J.G., Newsham I., Wu Y., Lewis L., Han Y., Voight B.F., Lim E., Rossin E., Kirby A., Flannick J., Fromer M., Shakir K., Fennell T., Garimella K., Banks E., Poplin R., Gabriel S., DePristo M., Wimbish J.R., Boone B.E., Levy S.E., Betancur C., Sunyaev S., Boerwinkle E., Buxbaum J.D., Cook E.H., Devlin B., Gibbs R.A., Roeder K., Schellenberg G.D., Sutcliffe J.S., Daly M.J. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nat. Adv. 2012, (Online publication).
94. Nicholls R.D., Knepper J.L. Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu. Rev. Genomics Hum. Genet. 2001, 2:153-175.
95. Nimchinsky E.A., Oberlander A.M., Svoboda K. Abnormal development of dendritic spines in FMR1 knock-out mice. J. Neurosci. 2001, 21:5139-5146.
96. Noh H.J., Ponting C.P., Boulding H.C., Meader S., Betancur C., Buxbaum J.D., Pinto D., Marshall C.R., Lionel A.C., Scherer S.W., Webber C. Network topologies and convergent aetiologies arising from deletions and duplications observed in individuals with autism. PLOS Genet. 2013, 9:e1003523.
97. O'Roak B.J., Vives L., Girirajan S., Karakoc E., Krumm N., Coe B.P., Levy R., Ko A., Lee C., Smith J.D., Turner E.H., Stanaway I.B., Vernot B., Malig M., Baker C., Reilly B., Akey J.M., Borenstein E., Rieder M.J., Nickerson D.A., Bernier R., Shendure J., Eichler E.E. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nat. Adv. 2012, (Online publication).
98. Oberlaender M., Ramirez A., Bruno R.M. Sensory experience restructures thalamocortical axons during adulthood. Neuron 2012, 74:648-655.
99. Ozkan E.D., Creson T.K., Kramar E.A., Rojas C., Seese R.R., Babyan A.H., Shi Y., Lucero R., Xu X., Noebels J.L., Miller C.A., Lynch G., Rumbaugh G. Reduced cognition in Syngap1 mutants is caused by isolated damage within developing forebrain excitatory neurons. Neuron 2014, 82:1317-1333.
100. Peca J., Feliciano C., Ting J.T., Wang W., Wells M.F., Venkatraman T.N., Lascola C.D., Fu Z., Feng G. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 2011, 472:437-442.
101. Pfeiffer B.E., Huber K.M. The state of synapses in fragile X syndrome. Neuroscientist 2009, 15:549-567.
102. Pizzorusso T., Medini P., Berardi N., Chierzi S., Fawcett J.W., Maffei L. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 2002, 298:1248-1251.
103. Portera-Cailliau C. Which comes first in fragile X syndrome, dendritic spine dysgenesis or defects in circuit plasticity?. Neuroscientist 2012, 18(1):28-44. 10.1177/1073858410395322.
104. Powell A.D., Gill K.K., Saintot P.P., Jiruska P., Chelly J., Billuart P., Jefferys J.G. Rapid reversal of impaired inhibitory and excitatory transmission but not spine dysgenesis in a mouse model of mental retardation. J. Physiol. 2012, 590:763-776.
105. Purpura D.P. Dendritic spine "dysgenesis" and mental retardation. Science 1974, 186:1126-1128.
106. Ramakers G.J. Rho proteins, mental retardation and the cellular basis of cognition. Trends Neurosci. 2002, 25:191-199.
107. Romijn H.J., Hofman M.A., Gramsbergen A. At what age is the developing cerebral cortex of the rat comparable to that of the full-term newborn human baby?. Early Hum. Dev. 1991, 26:61-67.
108. Ruano D., Abecasis G.R., Glaser B., Lips E.S., Cornelisse L.N., de Jong A.P., Evans D.M., Davey Smith G., Timpson N.J., Smit A.B., Heutink P., Verhage M., Posthuma D. Functional gene group analysis reveals a role of synaptic heterotrimeric G proteins in cognitive ability. Am. J. Hum. Genet. 2010, 86:113-125.
109. Rubenstein J.L., Merzenich M.M. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2003, 2:255-267.
110. Sanders S.J., Murtha M.T., Gupta A.R., Murdoch J.D., Raubeson M.J., Willsey A.J., Ercan-Sencicek A.G., DiLullo N.M., Parikshak N.N., Stein J.L., Walker M.F., Ober G.T., Teran N.A., Song Y., El-Fishawy P., Murtha R.C., Choi M., Overton J.D., Bjornson R.D., Carriero N.J., Meyer K.A., Bilguvar K., Mane S.M., Sestan N., Lifton R.P., Gunel M., Roeder K., Geschwind D.H., Devlin B., State M.W. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012, 485:237-241.
111. Sato M., Stryker M.P. Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:5611-5616.
112. Schneider T., Przewlocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 2005, 30:80-89.
113. Semple B.D., Blomgren K., Gimlin K., Ferriero D.M., Noble-Haeusslein L.J. Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species. Prog. Neurobiol. 2013, 106-107:1-16.
114. State M.W., Sestan N. Neuroscience. The emerging biology of autism spectrum disorders. Science 2012, 337:1301-1303.
115. Su T., Fan H.X., Jiang T., Sun W.W., Den W.Y., Gao M.M., Chen S.Q., Zhao Q.H., Yi Y.H. Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome. Psychopharmacology (Berlin) 2011, 215:291-300.
116. Tuchman R., Rapin I. Epilepsy in autism. Lancet Neurol. 2002, 1:352-358.
117. Turrigiano G.G., Nelson S.B. Homeostatic plasticity in the developing nervous system. Nat. Rev. Neurosci. 2004, 5:97-107.
118. Tyzio R., Nardou R., Ferrari D.C., Tsintsadze T., Shahrokhi A., Eftekhari S., Khalilov I., Tsintsadze V., Brouchoud C., Chazal G., Lemonnier E., Lozovaya N., Burnashev N., Ben-Ari Y. Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring. Science 2014, 343:675-679.
119. van Bokhoven H. Genetic and epigenetic networks in intellectual disabilities. Annu. Rev. Genet. 2011, 45:81-104.
120. Vislay R.L., Martin B.S., Olmos-Serrano J.L., Kratovac S., Nelson D.L., Corbin J.G., Huntsman M.M. Homeostatic responses fail to correct defective amygdala inhibitory circuit maturation in fragile X syndrome. J. Neurosci. 2013, 33:7548-7558.
121. Voineagu I., Wang X., Johnston P., Lowe J.K., Tian Y., Horvath S., Mill J., Cantor R.M., Blencowe B.J., Geschwind D.H. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384.
122. Wang D.D., Kriegstein A.R. Blocking early GABA depolarization with bumetanide results in permanent alterations in cortical circuits and sensorimotor gating deficits. Cereb. Cortex 2011, 21:574-587.
123. Wang S.S., Kloth A.D., Badura A. The cerebellum, sensitive periods, and autism. Neuron 2014, 83:518-532.
124. Williams C.A., Beaudet A.L., Clayton-Smith J., Knoll J.H., Kyllerman M., Laan L.A., Magenis R.E., Moncla A., Schinzel A.A., Summers J.A., Wagstaff J. Angelman syndrome 2005: updated consensus for diagnostic criteria. Am. J. Med. Genet. A 2006, 140:413-418.
125. Workman A.D., Charvet C.J., Clancy B., Darlington R.B., Finlay B.L. Modeling transformations of neurodevelopmental sequences across mammalian species. J. Neurosci. 2013, 33:7368-7383.
126. Yashiro K., Riday T.T., Condon K.H., Roberts A.C., Bernardo D.R., Prakash R., Weinberg R.J., Ehlers M.D., Philpot B.D. Ube3a is required for experience-dependent maturation of the neocortex. Nat. Neurosci. 2009, 12:777-783.
127. Zimmerman A.W., Connors S.L. Maternal Influences on Fetal Neurodevelopment 2010.
128. Zoghbi H.Y., Bear M.F. Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb. Perspect. Biol. 2012, 4(3). 10.1101/cshperspect.a009886.